BlackRock Health Sciences Trust (BME) Fund Overview
BlackRock Health Sciences Trust (BME) — price $43.34 (-0.62%), as of the Oct 2, 2026 trading session.
Educational signal · not a buy or sell recommendation · How to read this
BlackRock Health Sciences Trust · BME
BlackRock Health Sciences Trust is a closed-end equity mutual fund managed by BlackRock Advisors, investing in health sciences and related sectors within the United States.
Price as of Oct 2, 2026
Key Statistics
Not scored: this is a debt/preferred or other non-common instrument, or its reported market value does not match its share basis.
Price & valuation
| Measure | Value |
|---|---|
| Latest provided price | $43.34 |
| Change on the day | -0.62% |
| Price / earnings (trailing) | 5.38 |
| Shares traded on the day | 42.5K |
Price & events
Watch the BME film — every key number, told as a short cinematic story
~2 min · open the film
What is BlackRock Health Sciences Trust (BME), and what does it report?
Short answer · as of
A current FMP business description is unavailable; the listing and provider classification below are the available identity facts. BlackRock Health Sciences Trust (BME) is the company analyzed here. In Q2 FY2026 it reported revenue of $31M and net income of $23M.
What do the latest results show for BlackRock Health Sciences Trust (BME)?
Short answer · as of
The most recent reported quarter, Q2 FY2026, carried revenue of $31M.
Quarterly income statement — 4 quarters
| Period | Revenue | Net income | EPS |
|---|---|---|---|
| Q2 FY2026 | $31M | $23M | $1.82 (diluted) |
| Q4 FY2025 | $23M | $81M | $6.23 (diluted) |
| Q2 FY2025 | $4M | -$4M | -$0.28 (diluted) |
| Q4 FY2024 | $37M | -$22M | -$1.70 (diluted) |
What are the financial strengths and risks for BlackRock Health Sciences Trust (BME)?
Short answer
The distress and quality screens read Piotroski F 6. Trailing ratios: ROE 14.3% · ROA 13.5% · earnings yield 13.9% · free-cash-flow yield 4.5%.
The records behind this page
Insider activity
Form 4 records via FMP · Most recent available transactions
- Transactions
- 12
- Identified insiders
- 2
- Purchases
- 0
- Sales
- 0
- Other transactions
- 12
Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent.
Common Questions About BME
These answers are editorial: 1 of these 1 answer is drawn from the BME research dossier (written Mar 16, 2026 by gemini-2.0-flash). Figures in this section are not part of the source register.
What are the main risks for BME?
The main risks for BME include regulatory changes in the healthcare industry, which could negatively impact the profitability of healthcare companies. Market fluctuations could also affect the value of the fund's holdings. An economic downturn could impact healthcare spending and reduce demand for healthcare services.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief.
Sources — records for every figure on this page (11 figures)
The 11 rows below are exactly the facts the evidence-backed sections of this page printed — the 10-second verdict, the MoonshotScore, price and market value, the five questions with their receipts, and the records behind this page. Known dates and sources are recorded on their own rows; an em dash or UNRECORDED tier preserves a stored observation without inventing either. The quarterly income statement is provider-standardized (FMP) under one row, and scale definitions — a 0-100 rating, the band ladder, the Piotroski 0–9 range — are fixed rather than measured. No number in those sections was generated by a model. The register does not cover quoted third-party headlines, the dated council readings, or the Frequently Asked Questions; each of those says where it came from where it stands.
"As of" is the date the value is true for where the source carries one — a quarter end, a filing date, a price close, the day the score was computed. A cached observation with no source date remains undated; the page publication date is not used as a substitute.
FMP — 9 facts from Financial Modeling Prep endpoint families
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
px.last | Latest provided price | $43.34 | FMP | Financial Modeling Prep (FMP) · quote — Dated to the US trading session the price belongs to, derived from the quote record's timestamp (weekend and pre-open reads roll back to the previous weekday; exchange holidays are not modelled). The record does not establish an exchange execution time. Retrieved 2026-10-05T08:44:37.767Z. | |
px.change | Change on the day | -0.62% | FMP | Financial Modeling Prep (FMP) · quote | |
px.change_abs | Change on the day, in dollars | −$0.27 | FMP | Financial Modeling Prep (FMP) · quote | |
px.pe | Price / earnings (trailing) | 5.38 | FMP | Financial Modeling Prep (FMP) · quote | |
px.volume | Shares traded on the day | 42.5K | FMP | Financial Modeling Prep (FMP) · quote | |
fin.q_revenue | Revenue, Q2 FY2026 | $31M | FMP | Financial Modeling Prep (FMP) · income statement (quarterly) | |
fin.q_income | Net income, Q2 FY2026 | $23M | FMP | Financial Modeling Prep (FMP) · income statement (quarterly) | |
fin.q_table | Quarterly income statement | 4 quarters through Q2 FY2026 | FMP | Financial Modeling Prep (FMP) · income statement (quarterly), as filed | |
own.insiders | Insider transactions via FMP | 12 transactions · 0 purchases, 0 sales, 12 other transactions · 2 identified insiders · most recent available transactions | FMP | Financial Modeling Prep (FMP), carrying Form 4 transaction records — Purchases and sales use the reported transaction category. Other transactions include awards, exercises, gifts, withholding and unclassified activity; an acquisition or disposition alone is not a purchase or sale. These records do not establish intent. |
UNRECORDED — 2 facts from stored observations whose source was not recorded
| Fact ID | Fact | Value as shown | As of | Tier | Source |
|---|---|---|---|---|---|
fin.scores | Distress and quality screens | Piotroski F 6 | UNRECORDED | Stored financial-scores observation — Captured 2026-10-04 · Expired observation | |
fin.ratios | Return and yield ratios (trailing twelve months) | ROE 14.3% · ROA 13.5% · earnings yield 13.9% · free-cash-flow yield 4.5% | — | UNRECORDED | Stored key metrics — Date unknown |
- Published
- Research standards
- Methodology · Editorial policy · Corrections
- Report a number
- sedat@stockexpertai.com
Data provided for informational purposes only.